Retatrutide 30mg
High-quantity 30mg formulation of Retatrutide for extended triple receptor agonist research. As a GIP/GLP-1/glucagon triple agonist in the highest clinical development stage, Retatrutide is an important research compound for the most advanced metabolic biology studies.
Specifications: 30mg lyophilized powder | Purity ≥99% (HPLC) | Store at −20°C
For Research Use Only. Not for human or veterinary use. This product is intended solely for in vitro and laboratory research. Not approved by the FDA. Not a drug, food, or cosmetic. Keep out of reach of children.
